header-image

EURETOS

About Euretos

Euretos provides contract research services and cloud access to the Euretos AI Platform for disease and drug research. We use AI technologies such as machine reading and learning, to create data driven disease insights into the systems biological, molecular mechanisms that drive phenotypes, disease pathology, toxicity and drug response.
These data driven disease insights help researchers to be more effective in fundamental disease research, preclinical discovery & clinical validation of targets, biomarkers and indications. Our machine reading technology interprets and connects hundreds of public databases and millions of scientific publications to provide the largest knowledge base where multi omics data is interlinked to literature, patents, experimental and clinical evidence.
State-of-the-art Machine & Deep Learning algorithms for cell type deconvolution, co-expression prediction and target perturbation analysis leverage this unique knowledge base to create highly insightful molecular disease models.

Company Profile

Year of establishment

2012

HQ location

Utrecht Science Park, Yalelaan 1
3584 CL, Utrecht
The Netherlands

Products and Services

1. In silico target identification (as a service)
2. In silico indication expansion (as a service)
3. Cloud access to Euretos AI Platform (product license)

Application

Our machine reading technology interprets and connects hundreds of public databases and millions of scientific publications to provide the largest knowledge base where multi omics data is interlinked to literature, patents, experimental and clinical evidence.
State-of-the-art Machine & Deep Learning algorithms for cell type deconvolution, co-expression prediction and target perturbation analysis leverage this unique knowledge base to create highly insightful molecular disease models.

These unique assets enable (pre)clinical researchers to take a translational systems biology approach by connecting multi-omics interactions, through cell-type involvement, to downstream pathways, phenotypes and disease pathologies.

Value Proposition

Enabling a systems biology approach to discovery of targets, biomarkers and indications

Find a video here!

EURETOS AI Platform

Carole Friederichs

Buisness Development Director

+31 6 2289 3993

Carole.friederichs@euretos.com

www.euretos.com